These observations led to an interesting development bifurcation : Melanotan I (Afamelanotide) continued as a skin peptide and in 2014 received approval as Scenesse for erythropoietic protoporphyria (a rare genetic disease with severe photosensitivity) Melanotan II was abandoned as a cutaneous drug PT-141 / Bremelanotide , a fragment of Melanotan II targeted at MC4R, was developed as a sexual stimulant and in 2019 approved as Vyleesi for hypoactive sexual desire disorder in women (HSDD) Second life in research and the cosmetic underground Melanotan II never reached commercial approval as a drug, but in the research community and cosmetic underground it became well known
Your body is miraculously designed to break down the foods you eat into macro and micronutrients that are essential for metabolism and energy production
Stoyanov GS, Lyutfi E, Georgieva R, Georgiev R, Dzhenkov DL, Petkova L, et al
Keep all items together in a clear, sealable bag for easy presentation at security checkpoints
Lisa shares a personal (and oddly delicious) story about a recurring thunking noise in her car and how it led her to rethink her approach to treats, cravings, and using planning to create freedom around food
FilosaMorgan Stanley Wealth ManagementChicagoIllinois - Chicago (Private Wealth)$1M$1.8B$1.5-2M$2-15MPhilip CowenWells Fargo AdvisorsChicagoIllinois - Chicago (Private Wealth)$1M$768M$5-75M$1-20MDallas FoxMerrill Private Wealth ManagementChicagoIllinois - Chicago (Private Wealth)$2.5M$2.9B$2.5-25M$2.5-85MJim ErtmannMerrill Private Wealth ManagementChicagoIllinois - Chicago (Private Wealth)$3M$844M$10-100M$5-50MMark MyersStifelChicagoIllinois - Chicago (Private Wealth)$1M$450M$5-50M$1-15MManny HodzicWilliam BlairChicagoIllinois - Chicago (Private Wealth)$2M$7.1B$22.5-35M$15-20MBrian F